Affirm (AFRM) Form 4: CFO exercises options, sells shares under 10b5-1 plan
Rhea-AI Filing Summary
Robert O'Hare, Chief Financial Officer of Affirm Holdings, Inc. (AFRM), reported multiple equity transactions on September 1-2, 2025. The Form 4 shows RSU vesting and option exercises that increased holdings and concurrent sales—including share withholding to satisfy taxes—executed under a Rule 10b5-1 trading plan adopted December 6, 2024. On September 1, 2025 the reporting person acquired 23,029 shares and had 23,029 shares beneficially owned following that transaction; subsequent activity on September 1-2 included tax-withheld shares (11,697) and a sequence of option exercises, RSU settlements and open-market sales at weighted-average prices in the $81.69–$85.50 range. The final non-derivative line shows a disposition that reduced the reported Class A common stock position to 0 shares for that line, while Table II lists multiple RSU and option holdings and resulting beneficial ownership counts for derivative awards.
Positive
- Transactions were conducted under a Rule 10b5-1 trading plan adopted 12/06/2024, providing an affirmative defense framework
- Detailed disclosure of tax-withheld shares (11,697 shares) and weighted-average sale price ranges enhances transparency
- Vesting and option schedules are fully explained in footnotes, clarifying the basis for acquisitions and exercises
Negative
- Insider executed multiple open-market sales (sales on 09/02/2025) reducing a reported non-derivative position to 0 shares for that line
- Significant share disposals at prices in the ~$81.69–$85.50 range may represent material insider liquidity that could be viewed negatively by some investors
Insights
TL;DR: Insider executed option exercises and sold shares under a 10b5-1 plan; transactions appear routine and tax-driven.
The Form 4 documents material insider activity by CFO Robert O'Hare, including RSU settlements, option exercises and open-market sales on 09/01/2025 and 09/02/2025 effected pursuant to a Rule 10b5-1 plan adopted 12/06/2024. Notable items include shares withheld to satisfy tax obligations (11,697 shares) and weighted-average sale price ranges disclosed for sales (approximately $81.69–$85.50 per share). The transactions changed reported beneficial ownership counts across multiple lines, with one non-derivative line reduced to 0 following sales. This filing provides transparency on insider liquidity but does not disclose company operational results.
TL;DR: Use of a documented 10b5-1 plan and tax-withholding is consistent with standard insider compliance practices.
The reporting person explicitly states the trading activity was effected under a 10b5-1 trading plan adopted 12/06/2024, which supports an affirmative defense to insider trading allegations if properly implemented. The report also discloses shares withheld to cover tax obligations upon RSU settlement (11,697 shares). The filing includes full footnotes on vesting schedules and exercise vesting timelines, demonstrating standard governance disclosure for executive equity compensation and related dispositions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 11,988 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 933 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 2,837 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 1,280 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 2,427 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 626 | $0.00 | -- |
| Exercise | Class A Common Stock | 933 | $41.80 | $39K |
| Exercise | Class A Common Stock | 2,837 | $17.19 | $49K |
| Exercise | Class A Common Stock | 1,280 | $22.30 | $29K |
| Exercise | Class A Common Stock | 2,427 | $23.35 | $57K |
| Exercise | Class A Common Stock | 626 | $57.59 | $36K |
| Sale | Class A Common Stock | 12,190 | $82.24 | $1.00M |
| Sale | Class A Common Stock | 8,582 | $83.27 | $715K |
| Sale | Class A Common Stock | 6,700 | $84.09 | $563K |
| Sale | Class A Common Stock | 3,951 | $85.28 | $337K |
| Exercise | Restricted Stock Units | 1,496 | $0.00 | -- |
| Exercise | Restricted Stock Units | 4,544 | $0.00 | -- |
| Exercise | Restricted Stock Units | 2,102 | $0.00 | -- |
| Exercise | Restricted Stock Units | 5,019 | $0.00 | -- |
| Exercise | Restricted Stock Units | 8,511 | $0.00 | -- |
| Exercise | Restricted Stock Units | 1,357 | $0.00 | -- |
| Exercise | Class A Common Stock | 23,029 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 11,697 | $88.46 | $1.03M |
| Exercise | Class A Common Stock | 11,988 | $44.06 | $528K |
Footnotes (1)
- Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the settlement of shares of Common Stock underlying the Reporting Person's restricted stock units that vested on September 1, 2025. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2024. Represents the weighted average sale price of the shares sold from $81.69 to $82.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents the weighted average sale price of the shares sold from $82.73 to $83.72 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents the weighted average sale price of the shares sold from $83.73 to $84.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents the weighted average sale price of the shares sold from $84.75 to $85.50 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock. With respect to the shares of Class A Common Stock underlying the RSUs, the RSUs vested in equal monthly installments from April 1, 2022 until August 1, 2023. Beginning September 1, 2023, the RSUs vest in equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. This grant has no expiration date. With respect to the shares of Class A Common Stock underlying the RSUs, the RSUs vested in equal monthly installments from August 1, 2022 until August 1, 2023. Beginning September 1, 2023, the RSUs vest in equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. This grant has no expiration date. With respect to the shares of Class A Common Stock underlying the RSUs, the RSUs vested in equal monthly installments from October 1, 2022 until August 1, 2023. Beginning September 1, 2023, the RSUs vest in equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. This grant has no expiration date. The RSUs vest as to 25% of the shares on September 1, 2024 and the remainder vest in 12 equal quarterly installments over the subsequent three years, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. The RSUs vest as to 25% of the shares on September 1, 2025 and the remainder vest in 12 equal quarterly installments over the subsequent three years, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. RSUs vest with respect to the shares of Class A Common Stock underlying the restricted stock units in equal quarterly installments for a period of four years beginning December 1, 2024, the vesting commencement date, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. The stock options vest as to 25% of the underlying shares on September 1, 2025 and the remainder vest in 36 equal monthly installments over the subsequent three years subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest in 48 equal monthly installments beginning April 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest in 48 equal monthly installments beginning August 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest as to 25% of the underlying shares on September 1, 2024 and the remainder vest in 36 equal monthly installments over the subsequent three years subject to the Reporting Person's continuous service with the Issuer as of each vesting date. The stock options vest in 48 equal monthly installments beginning December 1, 2024, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
